Included support
- ✓Hospital matching
- ✓Record review
- ✓Care coordination
- ✓Travel support
- ✓Interpretation support

Autologous hematopoietic stem cell transplantation (ASCT) may be considered when non-Hodgkin lymphoma is sensitive to induction or salvage chemotherapy and has a high risk of relapse, or when consolidation therapy is needed after relapse. The decision is influenced by factors such as pathological su
24–72h
响应时间
Approx. $15,000
起价
Varies by procedure
治疗周期
1+ options
合作医院
经过病例审核后,我们将根据治疗适配度推荐医院和城市。
Treatment brief
Review the treatment pathway, hospital options, estimated costs, and practical preparation in one place. The final recommendation is based on your records and a specialist review.
Hospital matching
Compare suitable hospitals and departments before you commit to travel.
Record review
Our team helps organise your medical records and first-step case information.
Care coordination
Support around scheduling, practical preparation, and treatment planning.
Travel support
Help with the practical side of arriving, attending appointments, and recovery.
Your care pathway
让我们为您协调治疗旅程。
Step 1
Share your diagnosis, records, and goals so the team can assess the case.
Step 2
Receive suitable options based on condition, budget, timeline, and city preference.
Step 3
Get support with invitation materials and practical travel planning.
Step 4
The team supports your arrival, appointments, and care coordination in China.
Step 5
Continue with aftercare planning and remote follow-up after returning home.
Autologous hematopoietic stem cell transplantation typically begins with drug mobilization to move hematopoietic stem cells into the peripheral blood; these are then collected using apheresis equipment and cryopreserved. After evaluation, high-dose chemotherapy is administered as preconditioning to reduce the tumor burden and create space for hematopoiesis, followed by reinfusion of the previously stored stem cells. During treatment, blood counts, infection, and organ function are routinely monitored, with blood transfusions, anti-infection measures, and nutritional support provided as needed. The overall goal is to promote hematopoietic reconstitution and a smooth discharge. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.
Including preoperative evaluation, hospitalization, and postoperative follow-up, it is recommended to stay in China for approximately 6–10 weeks; the specific duration depends on bed and examination arrangements and individual recovery.
Recovery snapshot
Recovery time and follow-up depend on the procedure and your clinical situation. Your hospital team confirms the schedule before treatment, while our coordinators help organise the practical details around it.
Tell us about your Non-Hodgkin Lymphoma case and we will help match you with the right hospital, specialist, and travel pathway.
Suitability is confirmed after a qualified clinician reviews your diagnosis and records.
Risks, alternatives, expected outcomes, and limitations must be explained by the treating hospital.
Appointment and treatment timing depends on clinical review, hospital capacity, visa readiness, and scheduling.
Prices are case-specific. A written estimate should be confirmed by the hospital before travel.
Medical Tourism China provides coordination and general information, not medical advice. Final diagnosis, eligibility, treatment decisions, risks, fees, and follow-up remain with the licensed treating hospital.
来源:医院及医疗协调资料;更新时间:2026年7月。治疗适用性、费用和时间须以医院审核结果为准。